NCT05833360View on ClinicalTrials.gov

Prospective Study of oncRNA Stratification of Cancer by Size and Stage

RecruitingOBSERVATIONAL
Enrollment

2,400

Participants

Timeline

Start Date

July 14, 2023

Primary Completion Date

July 14, 2030

Study Completion Date

July 14, 2030

Conditions
Cancer
Interventions
DEVICE

Exai oncRNA blood test

A phlebotomist will collect approximately 40 ml (about 2-3 tablespoons) of blood from the subjects after consent. The Exai oncRNA blood test will be run on the blood samples.

Trial Locations (2)

89502

RECRUITING

Renown Health, Reno

94303

RECRUITING

Exai Bio Inc., Palo Alto

Sponsors

Lead Sponsor

Exai Bio Inc.
All Listed Sponsors
lead

Exai Bio Inc.

INDUSTRY